Early treatment of glucose toxicity with sitagliptin prevent progression of arteriosclerosis in cardiovascular disease patients
Not Applicable
Recruiting
- Conditions
- more than 50% coronary artery stenosis with diabetes, including impaired glucose tolerance
- Registration Number
- JPRN-UMIN000006432
- Lead Sponsor
- Cardiovascular Center,Anjo Kosei Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Any subject who applies to the article below shall be excluded. 1) Patients on oral antidiabetic or insulin preparation 2) Patients with a history of ileus or undergone laparotomy 3) Patients with severe liver dysfunction or renal dysfunction 4) Patients with serious case of ketosis or diabetical coma, or precoma 5) Patients with severe infection disease, or in the perioperative period, or with extreme trauma 6)Patient who caused myocardial infarction within the past six months 7) Patients with a history of sensitivity to Sitagliptin 8) Pregnant or possibly pregnant women 9) Patients judged by the investigator/subinvestigator to be ineligible for some other reason
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method